Assisted Reproductive Technology Market Size & Forecast 2034
The global assisted reproductive technology (ART) market was valued at USD 23.54 billion in 2024 and is projected to grow at a CAGR of 6.50% during 20252034, according to
Expert Market Research. ART includes a range of medical procedures used to treat infertility caused by conditions such as sexually transmitted infections (STIs), endometriosis, polycystic ovary syndrome (PCOS), and primary ovarian insufficiency (POI). Infertility is a growing global concern, affecting about one in six people of reproductive age. As awareness of ART grows and healthcare technologies advance, demand for assisted reproductive solutions continues to riseespecially as lifestyle patterns shift and many individuals delay parenthood.
Assisted Reproductive Technology Market Share
Market share in the ART industry is largely concentrated in North America and Europe, where advanced healthcare systems and regulatory support contribute to greater access to fertility treatments. Europe accounts for a significant share, backed by favorable reimbursement policies and government-funded fertility programs. North America, led by the United States, is also a key market, with increasing acceptance of ART and widespread technological integration in clinics.
Asia Pacific is emerging as the fastest-growing region, driven by rising infertility rates, increasing affordability, and the expansion of medical tourism for fertility treatment. On the product side, in-vitro fertilization (IVF) holds the largest share due to its higher success rates and wide applicability. Among end users, fertility clinics dominate the landscape because of their specialized offerings, advanced equipment, and volume of procedures.
Assisted Reproductive Technology Market Growth and Trends
Several factors are propelling the growth of the assisted reproductive technology market:
-
Increase in Infertility Cases: Environmental stressors, sedentary lifestyles, rising obesity rates, and delayed pregnancies have all contributed to a growing number of infertility cases worldwide.
-
Technological Innovation: Advances in embryo freezing, time-lapse imaging, and preimplantation genetic testing (PGT) have improved clinical outcomes and raised success rates.
-
Legal and Social Shifts: Changes in social norms and legal frameworksespecially in support of same-sex couples and single-parent familiesare broadening the target demographic for ART.
-
Fertility Preservation: Theres growing interest in egg and sperm preservation, particularly among cancer patients and career-focused individuals seeking to delay reproduction.
-
AI Integration: Machine learning and AI tools are being adopted for embryo grading, hormone monitoring, and treatment planning, allowing for more personalized and effective care.
Assisted Reproductive Technology Market Case Studies and News
-
Merck KGaA has unveiled a digital fertility platform aimed at improving patient monitoring and outcomes in IVF procedures.
-
FUJIFILM Irvine Scientific launched an innovative embryo culture medium, improving embryo growth and transfer success.
-
Vitrolife AB acquired Igenomix, strengthening its genetic testing capabilities and expanding its influence in personalized reproductive medicine.
-
Cyprus IVF Centre expanded its collaboration network to offer more affordable and efficient ART services across borders.
-
CooperSurgical, Inc. introduced new IVF lab equipment and embryo transfer catheters designed to optimize fertilization conditions.
These real-world innovations reflect a broader trend of technology-driven ART, where precision, personalization, and accessibility are becoming critical to success.
Assisted Reproductive Technology Market Analysis
The ART market is highly competitive and dynamic, with numerous global and regional players competing on the basis of technology, treatment success rates, and affordability.
-
North America continues to lead innovation, supported by increasing insurance coverage and the growth of specialty fertility clinics.
-
Europe benefits from public healthcare initiatives and liberal policies that support ART procedures across a broader population base.
-
Asia Pacific is a high-potential market due to cost advantages and rising awareness, with countries like India, Thailand, and Malaysia becoming fertility tourism hubs.
-
Latin America and the Middle East & Africa show gradual market growth, with urban centers witnessing the expansion of ART services.
Regulatory policies vary significantly by region. In some European nations, ART is heavily regulated, whereas in others, such as the U.S. and parts of Asia, the private sector plays a larger role in treatment access and innovation.
Market Segmentation
By Type
-
In-Vitro Fertilization (IVF)
-
Artificial Insemination
By Product
-
Instrument
-
Accessory & Disposable
-
Reagent & Media
By Age
-
Women Younger Than Age 35
-
Women Older Than Age 35
By Application
-
Frozen Embryo Replacement (FER)
-
Surrogacy
-
Ovulation Induction
-
Others
By End User
-
Fertility Clinics & Other Facilities
-
Hospitals & Others
By Region
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East and Africa
Key Players in the Assisted Reproductive Technology Market
-
Microm U.K. Ltd.
-
CooperSurgical, Inc.
-
FUJIFILM Irvine Scientific
-
Cyprus IVF Centre
-
Vita Altera IVF Center
-
Cryolab Ltd.
-
Vitrolife AB
-
European Sperm Bank
-
Bloom IVF Centre
-
Merck KGaA
The ART market is evolving rapidly, with strong emphasis on patient-centered care, automation, and global accessibility. As reproductive health continues to take center stage in public and private health agendas, assisted reproductive technology is expected to remain a vital component of modern fertility care across the globe.
Check Out More Reports
United States Medical Spa Market
South Korea Smart Healthcare Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
